We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study

    Introduction

    A higher levodopa dose is a risk factor for motor complications in Parkinson’s disease (PD). Istradefylline (IST) is used as adjunctive...

    Taku Hatano, Renpei Sengoku, ... Osamu Kano in Neurology and Therapy
    Article Open access 16 January 2024
  2. Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects

    Background and Objectives

    The treatment of Parkinson’s disease (PD) is still symptomatic since disease-modifying treatments for PD are not available....

    Johanna Tuunainen, Noora Sjöstedt, ... Marjo Yliperttula in European Journal of Drug Metabolism and Pharmacokinetics
    Article 30 October 2022
  3. High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials

    Background

    Levodopa is the most commonly used first-line drug for Parkinson’s disease. However, during the period of medication, the generation of...

    Zeya Yan, Wei Wang, ... Gang Chen in Neurological Sciences
    Article 30 July 2022
  4. An updated calculator for determining levodopa-equivalent dose

    Calculation of levodopa-equivalent dose in Parkinson’s disease has become common in research, but is also a useful tool in clinical practice,...

    D. Nyholm, W. H. Jost in Neurological Research and Practice
    Article Open access 25 October 2021
  5. Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease

    Levodopa is currently the standard of care treatment for Parkinson’s disease, but chronic therapy has been linked to motor complications. Designing a...

    Yehuda Arav, Assaf Zohar in Scientific Reports
    Article Open access 22 September 2023
  6. Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study

    Hypokinetic dysarthria (HD) is a difficult-to-treat symptom affecting quality of life in patients with Parkinson’s disease (PD). Levodopa may...

    Martina Mračková, Radek Mareček, ... Irena Rektorová in Journal of Neural Transmission
    Article 09 November 2023
  7. Inhaled levodopa for threatening impending OFF episodes in managing Parkinson’s disease

    Parkinson’s disease (PD) is a neurodegenerative disorder that leads to the degeneration of dopaminergic neurons resulting in a widespread pathology...

    Wolfgang H. Jost, Jaime Kulisevsky, Peter A. LeWitt in Journal of Neural Transmission
    Article 23 April 2023
  8. Subcutaneous Levodopa: A New Engine for the Vintage Molecule

    The management of Parkinson’s disease (PD) continues to evolve with advancements in non-oral levodopa-based therapies aiming to provide continuous...

    Karolina Poplawska-Domaszewicz, Lucia Batzu, ... K. Ray Chaudhuri in Neurology and Therapy
    Article Open access 14 June 2024
  9. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study

    Background

    Levodopa remains the most effective symptomatic treatment for Parkinson’s disease (PD) more than 50 years after its clinical introduction....

    Taku Hatano, Osamu Kano, ... Hiroshi Nagayama in BMC Neurology
    Article Open access 03 March 2022
  10. Apprends-moi l'art des petits pas: Levodopa, Carbidopa Intestinal Gel plus Entacapone

    We are always looking for the big breakthrough, ideally a cure for our advanced Parkinson’s disease (aPD) patients. As long as this does not happen...

    Wolfgang H. Jost in Journal of Neural Transmission
    Article Open access 28 April 2023
  11. Effect of levodopa on postural blood pressure changes in Parkinson disease: a randomized crossover study

    Purpose

    We investigated the effect of levodopa on postural blood pressure changes in individuals with Parkinson disease (PD) with (PD +OH ) and without...

    Timi Earl, Amani Jridi, ... Guillaume Lamotte in Clinical Autonomic Research
    Article 01 February 2024
  12. The effect of levodopa treatment on vascular endothelial function in Parkinson’s disease

    Objective

    There has been increasing awareness that micro-vascular alteration or vascular inflammation has been associated with levodopa-induced...

    Min Seung Kim, Don Gueu Park, ... Jung Han Yoon in Journal of Neurology
    Article 15 February 2023
  13. A video-atlas of levodopa-induced dyskinesia in Parkinson’s disease: terminology matters

    Dyskinesia is a common complication of long-term levodopa therapy in patients with Parkinson’s disease (PD), which often worsens the quality of life....

    Harsh V. Gupta, Abhishek Lenka, ... Alfonso Fasano in Neurological Sciences
    Article 21 November 2023
  14. Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson’s disease

    Parkinson’s disease is managed using levodopa; however, as Parkinson’s disease progresses, patients require increased doses of levodopa, which can...

    Gang Cheng, Micael Hardy, ... Balaraman Kalyanaraman in Communications Biology
    Article Open access 30 May 2024
  15. Unlocking the potential: T1-weighed MRI as a powerful predictor of levodopa response in Parkinson’s disease

    Background

    The efficacy of levodopa, the most crucial metric for Parkinson’s disease diagnosis and treatment, is traditionally gauged through the...

    Junyi Yan, Xufang Luo, ... Chencheng Zhang in Insights into Imaging
    Article Open access 09 June 2024
  16. Kinect-based objective assessment of the acute levodopa challenge test in parkinsonism: a feasibility study

    Introduction

    The acute levodopa challenge test (ALCT) is an important and valuable examination but there are still some shortcomings with it. We aimed...

    Ronghua Hong, Zhuang Wu, ... Ling**g ** in Neurological Sciences
    Article 06 January 2024
Did you find what you were looking for? Share feedback.